Acta Neurologica Scandinavica

Papers
(The H4-Index of Acta Neurologica Scandinavica is 24. The table below lists those papers that are above that threshold based on CrossRef citation counts [max. 250 papers]. The publications cover those that have been published in the past four years, i.e., from 2020-04-01 to 2024-04-01.)
ArticleCitations
Neurological Manifestations of COVID‐19: A systematic review and current update281
Neurological side effects of SARS‐CoV‐2 vaccinations100
The potential neurological effect of the COVID‐19 vaccines: A review81
Epilepsy in time of COVID‐19: A survey‐based study70
Effect of COVID‐19 pandemic on stroke admission rates in a Norwegian population56
The Non‐Motor Symptoms Scale in Parkinson’s disease: Validation and use49
Efficacy and safety of rituximab in autoimmune encephalitis: A meta‐analysis43
Neutrophil–lymphocyte ratio in acute ischemic stroke: Immunopathology, management, and prognosis33
Cannabidiol efficacy independent of clobazam: Meta‐analysis of four randomized controlled trials32
Glymphatic dysfunction in isolated REM sleep behavior disorder31
In‐hospital acute stroke workflow in acute stroke – Systems‐based approaches30
COVID‐19 presentations and outcome in patients with epilepsy29
Blood biomarkers for Alzheimer's disease and related disorders28
Safety and efficacy of Direct Oral Anticoagulants in cerebral venous thrombosis: A meta‐analysis28
Parkinson’s disease and intensive exercise therapy — An updated systematic review and meta‐analysis27
Neutrophil‐to‐lymphocyte ratio and CRP as biomarkers in multiple sclerosis: A systematic review27
Refractory migraine profile in CGRP‐monoclonal antibodies scenario26
Neurophysiological impairments in multiple sclerosis—Central and peripheral motor pathways25
Air pollution, a possible risk factor for multiple sclerosis25
EEG and Coma Recovery Scale‐Revised prediction of neurological outcome in Disorder of Consciousness patients25
Blood biomarkers in ALS : challenges, applications and novel frontiers24
SARS‐CoV‐2 vaccines are not free of neurological side effects24
Trigeminal neuralgia in multiple sclerosis: Prevalence and association with demyelination24
Persistent olfactory dysfunction after COVID‐19 is associated with reduced perfusion in the frontal lobe24
Pyridoxine, folate and cobalamin for migraine: A systematic review24
0.037945985794067